Search criteria ⓘ Use this form to refine search results.
Full-text search supports keyword queries with ranking and filtering.
You can combine vendor, product, and sources to narrow results.
Enable “Apply ordering” to sort by date instead of relevance.

2 vulnerabilities found for Oracle Life Sciences Empirica Signal by Oracle Corporation

CVE-2026-21997 (GCVE-0-2026-21997)

Vulnerability from nvd – Published: 2026-04-21 20:34 – Updated: 2026-04-22 14:03
VLAI?
Summary
Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).
Severity ?
8.5 (High)
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N
CWE
  • Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data.
Assigner
References
Impacted products
Vendor Product Version
Oracle Corporation Oracle Life Sciences Empirica Signal Affected: 9.2.1 , ≤ 9.2.3 (custom)
Create a notification for this product.
Show details on NVD website
To clipboard 

{
  "containers": {
    "adp": [
      {
        "metrics": [
          {
            "other": {
              "content": {
                "id": "CVE-2026-21997",
                "options": [
                  {
                    "Exploitation": "none"
                  },
                  {
                    "Automatable": "no"
                  },
                  {
                    "Technical Impact": "partial"
                  }
                ],
                "role": "CISA Coordinator",
                "timestamp": "2026-04-22T14:02:55.730217Z",
                "version": "2.0.3"
              },
              "type": "ssvc"
            }
          }
        ],
        "problemTypes": [
          {
            "descriptions": [
              {
                "cweId": "CWE-284",
                "description": "CWE-284 Improper Access Control",
                "lang": "en",
                "type": "CWE"
              }
            ]
          }
        ],
        "providerMetadata": {
          "dateUpdated": "2026-04-22T14:03:00.137Z",
          "orgId": "134c704f-9b21-4f2e-91b3-4a467353bcc0",
          "shortName": "CISA-ADP"
        },
        "title": "CISA ADP Vulnrichment"
      }
    ],
    "cna": {
      "affected": [
        {
          "product": "Oracle Life Sciences Empirica Signal",
          "vendor": "Oracle Corporation",
          "versions": [
            {
              "lessThanOrEqual": "9.2.3",
              "status": "affected",
              "version": "9.2.1",
              "versionType": "custom"
            }
          ]
        }
      ],
      "cpeApplicability": [
        {
          "nodes": [
            {
              "cpeMatch": [
                {
                  "criteria": "cpe:2.3:a:oracle:life_sciences_empirica_signal:*:*:*:*:*:*:*:*",
                  "versionEndIncluding": "9.2.3",
                  "versionStartIncluding": "9.2.1",
                  "vulnerable": true
                }
              ],
              "negate": false,
              "operator": "OR"
            }
          ]
        }
      ],
      "descriptions": [
        {
          "lang": "en-US",
          "value": "Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core).  Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal.  While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change).  Successful attacks of this vulnerability can result in  unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as  unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts).  CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N)."
        }
      ],
      "metrics": [
        {
          "cvssV3_1": {
            "attackComplexity": "LOW",
            "attackVector": "NETWORK",
            "availabilityImpact": "NONE",
            "baseScore": 8.5,
            "baseSeverity": "HIGH",
            "confidentialityImpact": "LOW",
            "integrityImpact": "HIGH",
            "privilegesRequired": "LOW",
            "scope": "CHANGED",
            "userInteraction": "NONE",
            "vectorString": "CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N",
            "version": "3.1"
          }
        }
      ],
      "problemTypes": [
        {
          "descriptions": [
            {
              "description": "Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal.  While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change).  Successful attacks of this vulnerability can result in  unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as  unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data.",
              "lang": "en-US"
            }
          ]
        }
      ],
      "providerMetadata": {
        "dateUpdated": "2026-04-21T20:34:58.883Z",
        "orgId": "43595867-4340-4103-b7a2-9a5208d29a85",
        "shortName": "oracle"
      },
      "references": [
        {
          "name": "Oracle Advisory",
          "tags": [
            "vendor-advisory"
          ],
          "url": "https://www.oracle.com/security-alerts/cpuapr2026.html"
        }
      ]
    }
  },
  "cveMetadata": {
    "assignerOrgId": "43595867-4340-4103-b7a2-9a5208d29a85",
    "assignerShortName": "oracle",
    "cveId": "CVE-2026-21997",
    "datePublished": "2026-04-21T20:34:58.883Z",
    "dateReserved": "2026-01-05T18:07:34.723Z",
    "dateUpdated": "2026-04-22T14:03:00.137Z",
    "state": "PUBLISHED"
  },
  "dataType": "CVE_RECORD",
  "dataVersion": "5.2"
}

CVE-2026-21997 (GCVE-0-2026-21997)

Vulnerability from cvelistv5 – Published: 2026-04-21 20:34 – Updated: 2026-04-22 14:03
VLAI?
Summary
Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).
Severity ?
8.5 (High)
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N
CWE
  • Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data.
Assigner
References
Impacted products
Vendor Product Version
Oracle Corporation Oracle Life Sciences Empirica Signal Affected: 9.2.1 , ≤ 9.2.3 (custom)
Create a notification for this product.
Show details on NVD website
To clipboard 

{
  "containers": {
    "adp": [
      {
        "metrics": [
          {
            "other": {
              "content": {
                "id": "CVE-2026-21997",
                "options": [
                  {
                    "Exploitation": "none"
                  },
                  {
                    "Automatable": "no"
                  },
                  {
                    "Technical Impact": "partial"
                  }
                ],
                "role": "CISA Coordinator",
                "timestamp": "2026-04-22T14:02:55.730217Z",
                "version": "2.0.3"
              },
              "type": "ssvc"
            }
          }
        ],
        "problemTypes": [
          {
            "descriptions": [
              {
                "cweId": "CWE-284",
                "description": "CWE-284 Improper Access Control",
                "lang": "en",
                "type": "CWE"
              }
            ]
          }
        ],
        "providerMetadata": {
          "dateUpdated": "2026-04-22T14:03:00.137Z",
          "orgId": "134c704f-9b21-4f2e-91b3-4a467353bcc0",
          "shortName": "CISA-ADP"
        },
        "title": "CISA ADP Vulnrichment"
      }
    ],
    "cna": {
      "affected": [
        {
          "product": "Oracle Life Sciences Empirica Signal",
          "vendor": "Oracle Corporation",
          "versions": [
            {
              "lessThanOrEqual": "9.2.3",
              "status": "affected",
              "version": "9.2.1",
              "versionType": "custom"
            }
          ]
        }
      ],
      "cpeApplicability": [
        {
          "nodes": [
            {
              "cpeMatch": [
                {
                  "criteria": "cpe:2.3:a:oracle:life_sciences_empirica_signal:*:*:*:*:*:*:*:*",
                  "versionEndIncluding": "9.2.3",
                  "versionStartIncluding": "9.2.1",
                  "vulnerable": true
                }
              ],
              "negate": false,
              "operator": "OR"
            }
          ]
        }
      ],
      "descriptions": [
        {
          "lang": "en-US",
          "value": "Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core).  Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal.  While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change).  Successful attacks of this vulnerability can result in  unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as  unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts).  CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N)."
        }
      ],
      "metrics": [
        {
          "cvssV3_1": {
            "attackComplexity": "LOW",
            "attackVector": "NETWORK",
            "availabilityImpact": "NONE",
            "baseScore": 8.5,
            "baseSeverity": "HIGH",
            "confidentialityImpact": "LOW",
            "integrityImpact": "HIGH",
            "privilegesRequired": "LOW",
            "scope": "CHANGED",
            "userInteraction": "NONE",
            "vectorString": "CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N",
            "version": "3.1"
          }
        }
      ],
      "problemTypes": [
        {
          "descriptions": [
            {
              "description": "Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal.  While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change).  Successful attacks of this vulnerability can result in  unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as  unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data.",
              "lang": "en-US"
            }
          ]
        }
      ],
      "providerMetadata": {
        "dateUpdated": "2026-04-21T20:34:58.883Z",
        "orgId": "43595867-4340-4103-b7a2-9a5208d29a85",
        "shortName": "oracle"
      },
      "references": [
        {
          "name": "Oracle Advisory",
          "tags": [
            "vendor-advisory"
          ],
          "url": "https://www.oracle.com/security-alerts/cpuapr2026.html"
        }
      ]
    }
  },
  "cveMetadata": {
    "assignerOrgId": "43595867-4340-4103-b7a2-9a5208d29a85",
    "assignerShortName": "oracle",
    "cveId": "CVE-2026-21997",
    "datePublished": "2026-04-21T20:34:58.883Z",
    "dateReserved": "2026-01-05T18:07:34.723Z",
    "dateUpdated": "2026-04-22T14:03:00.137Z",
    "state": "PUBLISHED"
  },
  "dataType": "CVE_RECORD",
  "dataVersion": "5.2"
}